U.S. market Closed. Opens in 5 hours 46 minutes

ORGO | Organogenesis Holdings Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ORGO we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is very good and Health is passable.

Valuation (52%)

Company Industry
P/E Ratio (TTM) -48.82 17.08
PEG Ratio (TTM) 0.32 -22.36
P/S Ratio (TTM) 0.83 5.30
P/B Ratio (TTM) 1.41 4.29
P/FCF Ratio (TTM) 43.57 8.03
Price to 5YR AVG Earnings Ratio 22.75 28.55
Price to 5YR AVG FCF Ratio -71.85 20.88

Profitability (10%)

Company Industry
ROA (TTM) -1.72% 2.70%
ROE (TTM) -2.77% 17.50%
Net Profit Margin (TTM) -1.70% -11.92%
ROIC 5YR AVG 10.11% 9.77%

Growth (73%)

4QTR AVG 3YR AVG 5YR AVG
EPS -241.10% 181.94% 78.73%
Revenue 3.28% 34.30% 19.06%
Net Income -239.56% 208.94% 95.03%
Cash Flow 1.96% 325.46% 188.17%

Health (56%)

Company Industry
Current Ratio (TTM) 2.73 2.50
Quick Ratio (TTM) 2.42 1.86
D/E Ratio (TTM) 0.29 -0.29
Interest Coverage (TTM) 11.54 11.93
Piotroski F-Score 5 6
Altman Z-Score 2.38 4.61
LTL to 5YR AVG FCF -11.76 4.48
Shares Outstanding Growth 5YR AVG 14.27% 29.67%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙